Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant

被引：10

作者：

Kovalenko, Angelina O. ^{[1
]}

Ryabchevskaya, Ekaterina M. ^{[1
]}

Evtushenko, Ekaterina A. ^{[1
]}

Manukhova, Tatiana I. ^{[1
]}

Kondakova, Olga A. ^{[1
]}

Ivanov, Peter A. ^{[1
]}

Arkhipenko, Marina V. ^{[1
]}

Gushchin, Vladimir A. ^{[1
,2
]}

Nikitin, Nikolai A. ^{[1
]}

Karpova, Olga V. ^{[1
]}

机构：

[1] Lomonosov Moscow State Univ, Fac Biol, Dept Virol, Moscow, Russia

[2] Minist Hlth Russian Federat, NF Gamaleya Natl Res Ctr Epidemiol & Microbiol, Moscow, Russia

来源：

FRONTIERS IN MICROBIOLOGY | 2022年 / 13卷

基金：

俄罗斯基础研究基金会;

关键词：

coronaviruses; vaccine candidate; plant virus; adjuvant; tobacco mosaic virus; structurally modified plant virus; RECEPTOR-BINDING DOMAIN; TOBACCO-MOSAIC-VIRUS; SARS-COV-2; SPIKE; SPHERICAL-PARTICLES; SARS-COV; PROTEIN; MUTATIONS; INFECTION; EPITOPES; VIRIONS;

D O I：

10.3389/fmicb.2022.845316

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A recombinant vaccine candidate has been developed based on the major coronaviruses' antigen (S protein) fragments and a novel adjuvant-spherical particles (SPs) formed during tobacco mosaic virus thermal remodeling. The receptor-binding domain and the highly conserved antigenic fragments of the S2 protein subunit were chosen for the design of recombinant coronavirus antigens. The set of three antigens (Co1, CoF, and PE) was developed and used to create a vaccine candidate composed of antigens and SPs (SPs + 3AG). Recognition of SPs + 3AG compositions by commercially available antibodies against spike proteins of SARS-CoV and SARS-CoV-2 was confirmed. The immunogenicity testing of these compositions in a mouse model showed that SPs improved immune response to the CoF and PE antigens. Total IgG titers against both proteins were 9-16 times higher than those to SPs. Neutralizing activity against SARS-CoV-2 in serum samples collected from hamsters immunized with the SPs + 3AG was demonstrated.

引用

页数：15

共 50 条

[1] Study of rubella candidate vaccine based on a structurally modified plant virus
Trifonova, Ekaterina A.
Zenin, Vladimir A.
Nikitin, Nikolai A.
Yurkova, Maria S.
Ryabchevskaya, Ekaterina M.
Putlyaev, Egor V.
Donchenko, Ekaterina K.
Kondakova, Olga A.
Fedorov, Alexey N.
Atabekov, Joseph G.
Karpova, Olga V.
ANTIVIRAL RESEARCH, 2017, 144 : 27 - 33
[2] Dataset on safety and protective efficacy studies of COVID-19 vaccine candidates based on structurally modified plant virus in female hamsters
Kovalenko, A. O.
Ryabchevskaya, E. M.
Evtushenko, E. A.
Kondakova, O. A.
Ivanov, P. A.
Arkhipenko, M. V.
Nikitin, N. A.
Karpova, O. V.
DATA IN BRIEF, 2023, 48
[3] A promising vaccine candidate against COVID-19
Wang, Xiwei
Tu, Wenwei
MOLECULAR BIOMEDICINE, 2020, 1 (01):
[4] A promising vaccine candidate against COVID-19
Xiwei Wang
Wenwei Tu
Molecular Biomedicine, 1
[5] Plant virus-based COVID-19 vaccine candidates
Steinmetz, N.
PHYTOPATHOLOGY, 2021, 111 (10) : 177 - 177
[6] An Inactivated Virus Candidate Vaccine to Prevent COVID-19
Mulligan, Mark J.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (10): : 943 - 945
[7] Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate
Nkanga, Christian Isalomboto
Ortega-Rivera, Oscar A.
Shin, Matthew D.
Moreno-Gonzalez, Miguel A.
Steinmetz, Nicole F.
BIOMACROMOLECULES, 2022, 23 (04) : 1812 - 1825
[8] Development of a candidate vaccine to HCV using a plant virus based adjuvant
Savard, Christian
Leclerc, Denis
VACCINE, 2008,
[9] Biosafety study of vaccine complexes based on structurally modified plant virus
Trifonova, E.
Ryabchevskaya, E.
Putlyaev, E.
Donchenko, E.
Kondakova, O.
Nikitin, N.
Atabekov, J.
Karpova, O.
FEBS JOURNAL, 2017, 284 : 377 - 378
[10] Vaccine against COVID-19
Picazo, Juan J.
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (06) : 569 - 598

← 1 2 3 4 5 →